Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Naltrexone extended release?Zepbound release date?Fda tirzepatide shortage resolved date?Mounjaro price japan 2025?Savella generic cost?
See the DrugPatentWatch profile for repatha
Repatha (evolocumab) is made by Amgen, the U.S. company that develops and sells the medicine. [1]
Repatha is part of the PCSK9 inhibitor class. Other drugs in the same class include Praluent (alirocumab), which is made by Sanofi and Regeneron. [2]
For the original brand product, Repatha is marketed by Amgen. Biosimilars are not applicable to this medicine because evolocumab is a monoclonal antibody; instead, PCSK9 inhibitors generally face competition through other branded drugs in the class (like Praluent), not biosimilar “Repatha” equivalents. [1][2] Sources: [1] https://www.drugs.com/repatha.html [2] https://www.drugs.com/condition/high-cholesterol.html
Other Questions About Repatha :